Ron Andrews

Ron Andrews

Direktor/Vorstandsmitglied bei PRECIPIO, INC.

Vermögen: 289 041 $ am 31.10.2026

66 Jahre
Health Technology
Health Services
Technology Services

Profil

Ronald Asbury Andrews was the founder of Bethesda Group Fund, founded in 2015, serving as Principal.
Current jobs include Executive Chairman at Dxcover Ltd. since 2023, Executive Chairman at SimBioSys, Inc. since 2022, Director at Oxford Immunotec Ltd. since 2015, Director at Mission Hospital Foundation, Director at Quest Diagnostics TB LLC since 2015, Independent Director at Cellmax, Inc. since 2023, Independent Director at Precipio, Inc. since 2021, Chief Business Officer & Director at Cerenome, Inc. starting 2026, Director at Precipio Diagnostics LLC, Trustee at Wofford College, and Member-Supervisory Board at Agendia, Inc. since 2023.
Former jobs include Chief Executive Officer-GE Molecular Diagnostics at Clarient, Inc. from 2010 to 2012, Chief Executive Officer-Clarient Business Unit at GE Healthcare, Inc. in 2012, Chief Executive Officer & Director at Insight Molecular Diagnostics, Inc. from 2018 to 2022, Chief Executive Officer & Director at Twinstrand Biosciences, Inc. from 2023 to 2024, Independent Non-Executive Director at Oxford Immunotec Global Ltd. from 2015 to 2021, Director at Cardiac Science Corp.
from 2009 to 2010, Independent Director at Orion Health Group Ltd. and Orion Health Ltd. from 2016 to 2018, Director at Insight Genetics, Inc. from 2015 to 2019, Vice President at Immucor, Inc., Vice President-Marketing at Roche Diagnostics Corp., President-Genetic Sciences Division at Thermo Fisher Scientific, Inc. from 2013 to 2014, Senior Vice President-Global Marketing at Roche Molecular Systems, Inc. from 2000 to 2004, Senior Marketing Manager-Business Unit Operations at Abbott Diagnostics, Inc., President-Medical Sciences at Life Technologies Corp.
from 2012 to 2013, Member-Governors Board at CancerLinQ LLC from 2016 to 2023, and Managing Partner at Ph Blueprint.
Education includes an undergraduate degree from Wofford College conferred in 1981.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
21.04.2026 15 796 ( 0,88 % ) 285 908 $ 31.10.2026
09.11.2026 1 843 ( 0,03 % ) 3 133 $ 31.10.2026

Aktive Positionen von Ron Andrews

UnternehmenPositionBeginn
PRECIPIO, INC. Direktor/Vorstandsmitglied 01.03.2021
CERENOME, INC. Direktor/Vorstandsmitglied 20.03.2026
Vorsitzender 06.09.2023
Vorsitzender 01.01.2022
Mission Hospital Foundation
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 01.01.2015
Direktor/Vorstandsmitglied 01.01.2015
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 06.04.2023
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -

Ehemalige bekannte Positionen von Ron Andrews

UnternehmenPositionEnde
░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Ron Andrews im Detail an

Ausbildung von Ron Andrews

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

64

Beziehungen ersten Grades

29

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen29

Health Technology

Health Services

Health Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Mission Hospital Foundation

Health Services

Health Technology

Commercial Services

Health Technology

Technology Services

Health Technology

Health Services

Technology Services

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

Health Services

Finance

Technology Services

Ph Blueprint

Health Technology

  1. Börse
  2. Insider
  3. Ron Andrews